Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Capecitabine × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 36 Stomach Neoplasms 17 Rectal Neoplasms 14 Colorectal Neoplasms 13 Triple Negative Breast Neoplasms 10 Neoplasm Metastasis 10 Adenocarcinoma Of Esophagus 7 Esophageal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Nasopharyngeal Carcinoma 5 Colonic Neoplasms 5 Adenocarcinoma 5 Recurrence 4 Neoplasms 4 Cholangiocarcinoma 4 Locally Advanced Rectal Cancer 3 Colorectal Cancer Metastatic 3 Brain Neoplasms 3 Anus Neoplasms 3 Somatostatinoma 2 Pathologic Complete Response 2 HER2-positive Gastric Cancer 2 Gallbladder Neoplasms 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Advanced Solid Tumour 2 Solid Cancer 1 Resectable Colon Cancer 1 Rectal Neoplasms Malignant 1 Pancreatic Neoplasms 1

Interventions

Cisplatin 8 Pemetrexed 7 Carboplatin 4 Platinum 3 Nivolumab 3 Ipilimumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 pembrolizumab 2 durvalumab 2 Cyclophosphamide 2 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Interleukin-2 1 In Situ Hybridization, Fluorescence 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡